Effects of Denosumab on the Pharmacokinetics of Etanercept

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

PostmenopausalOsteopeniaRheumatoid ArthritisOsteoporosis

Interventions

DRUG

Etanercept

Administered by subcutaneous injection once a week

DRUG

Denosumab

Administered by subcutaneous injection

Trial Locations (2)

Research Site, Duncansville

Research Site, Dallas